InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Valencia Catalina. Director active across 1 company, notably AXIM BIOTECHNOLOGIES, INC.. Cumulatively, 2 disclosures have been recorded. Split: 2 buys · 0 sell. Total volume traded: €100k. History available since 24 August 2022. The latest transaction was disclosed on 24 August 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations